These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 2516849

  • 1. Lymphokine-activated killer induction and its regulation by macrophages in malignant pleural effusions.
    Yanagawa H, Sone S, Nii A, Fukuta K, Nakanishi M, Maeda K, Honda M, Ogura T.
    Jpn J Cancer Res; 1989 Dec; 80(12):1220-7. PubMed ID: 2516849
    [Abstract] [Full Text] [Related]

  • 2. Phenotypes and lymphokine-activated killer activity of pleural cavity lymphocytes of lung cancer patients without malignant effusion.
    Takahashi K, Sone S, Kimura S, Ogura T, Monden Y.
    Chest; 1993 Jun; 103(6):1732-8. PubMed ID: 8404092
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-2-inducible killer activity and its regulation by blood monocytes from autologous lymphocytes of lung cancer patients.
    Sone S, Kunishige E, Fawzy F, Yanagawa H, Nii A, Maeda K, Atagi S, Heike Y, Nishioka Y, Mizuno K.
    Jpn J Cancer Res; 1991 Jun; 82(6):716-23. PubMed ID: 1649813
    [Abstract] [Full Text] [Related]

  • 4. [Induction by local injections of IL-2 of antitumor effector cells and secondary production of cytokines in malignant pleural effusion].
    Sone S, Yanagawa H, Nii A, Ozaki T, Ogura T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug; 30(8):1434-40. PubMed ID: 1434216
    [Abstract] [Full Text] [Related]

  • 5. Up-regulation by granulocyte-macrophage colony-stimulating factor (GM-CSF) of induction of lymphokine (IL-2)-activated killer (LAK) cells by human blood monocytes.
    Singh SM, Sone S, Inamura N, Ogura T.
    Int J Cancer; 1989 Jul 15; 44(1):170-6. PubMed ID: 2663733
    [Abstract] [Full Text] [Related]

  • 6. [The cytotoxicity of malignant pleural effusion lymphocytes and LAK cells against autologous tumor cells].
    Guo Y, Xing Z.
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Apr 15; 18(2):80-2, 127. PubMed ID: 7553955
    [Abstract] [Full Text] [Related]

  • 7. In vivo boosting of lung natural killer and lymphokine-activated killer cell activity by interleukin-2: comparison of systemic, intrapleural and inhalation routes.
    Flexman JP, Manning LS, Robinson BW.
    Clin Exp Immunol; 1990 Oct 15; 82(1):151-6. PubMed ID: 2208789
    [Abstract] [Full Text] [Related]

  • 8. Evidence that interleukin-4 suppression of lymphokine-activated killer cell induction is mediated through monocytes.
    Brooks B, Parry H, Lawry J, Rees R.
    Immunology; 1992 Feb 15; 75(2):343-8. PubMed ID: 1551696
    [Abstract] [Full Text] [Related]

  • 9. [Intrapleural transfer of LAK cells combined with rIL-2 in the treatment of advanced lung cancer with malignant pleural effusion].
    Li DJ.
    Zhonghua Zhong Liu Za Zhi; 1989 Jul 15; 11(4):294-6. PubMed ID: 2625114
    [Abstract] [Full Text] [Related]

  • 10. [Experimental and clinical studies on intrapleural instillations of interleukin-2 (IL-2) in patients with malignant pleural effusion].
    Suzuki H.
    Nihon Geka Gakkai Zasshi; 1989 Nov 15; 90(11):1922-31. PubMed ID: 2608022
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gamma-interferon enhances the cytotoxic activity of interleukin-2-induced peripheral blood lymphocyte (LAK) cells, tumor infiltrating lymphocytes (TIL), and effusion associated lymphocytes.
    Papamichail M, Baxevanis CN.
    J Chemother; 1992 Dec 15; 4(6):387-93. PubMed ID: 1287141
    [Abstract] [Full Text] [Related]

  • 13. Soluble factors produced by macrophages/monocytes inhibit lymphokine-activated killer activity in rat splenocyte cultures.
    Kuppen PJ, Eggermont AM, Quak RB, Marinelli A, van de Velde CJ, Fleuren GJ.
    Cancer Immunol Immunother; 1994 Jan 15; 38(1):61-7. PubMed ID: 8299120
    [Abstract] [Full Text] [Related]

  • 14. T cells and monocytes regulate the generation and functional activity of natural killer-derived lymphokine-activated killer cells.
    Atzpodien J, Gulati SC.
    Stem Cells; 1993 Nov 15; 11(6):511-8. PubMed ID: 8111310
    [Abstract] [Full Text] [Related]

  • 15. Killing of alveolar macrophages and of monocytes that have responded to granulocyte-macrophage colony-stimulating factor by human lymphokine-activated killer cells.
    Sone S, Inamura N, Singh SM, Okubo A, Yanagawa H, Nakanishi M, Ogura T.
    Jpn J Cancer Res; 1989 Jul 15; 80(7):662-9. PubMed ID: 2507489
    [Abstract] [Full Text] [Related]

  • 16. Granulocyte-macrophage colony-stimulating factor augments lymphokine-activated killer activity from pleural cavity mononuclear cells of lung cancer patients without malignant effusion.
    Takahashi K, Sone S, Saito S, Kamamura Y, Uyama T, Ogura T, Monden Y.
    Jpn J Cancer Res; 1995 Sep 15; 86(9):861-6. PubMed ID: 7591964
    [Abstract] [Full Text] [Related]

  • 17. Induction of lymphokine-activated killer activity by interleukin 4 in human lymphocytes preactivated by interleukin 2 in vivo or in vitro.
    Higuchi CM, Thompson JA, Lindgren CG, Gillis S, Widmer MB, Kern DE, Fefer A.
    Cancer Res; 1989 Dec 01; 49(23):6487-92. PubMed ID: 2479463
    [Abstract] [Full Text] [Related]

  • 18. Effects of human alveolar macrophages on the induction of lymphokine (IL 2)-activated killer cells.
    Sone S, Utsugi T, Nii A, Ogura T.
    J Immunol; 1987 Jul 01; 139(1):29-34. PubMed ID: 3495601
    [Abstract] [Full Text] [Related]

  • 19. Role of human blood monocytes in up-regulation of lymphokine (interleukin-2)-activated killer cell activity with cisplatin and FK-565.
    Sodhi A, Basu S.
    Nat Immun; 1992 Jul 01; 11(2):105-16. PubMed ID: 1498519
    [Abstract] [Full Text] [Related]

  • 20. Up-regulation of induction of lymphokine (IL-2)-activated killer (LAK) cell activity by FK-565 and cisplatin.
    Basu S, Sodhi A, Singh SM, Suresh A.
    Immunol Lett; 1991 Mar 01; 27(3):199-204. PubMed ID: 2060971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.